Feds Move To Axe Key DEA Marijuana Rules Clearing the Way for MMJ's FDA Compliant HD and MS Trials
Press Release

Feds Move To Axe Key DEA Marijuana Rules Clearing the Way for MMJ's FDA Compliant HD and MS Trials

"Trump's Deregulatory Mandate Is Finally Driving DEA Marijuana Policy Reform," states Duane Boise, CEO of MMJ BioPharma Cultivation.

Under President Trump's Executive Order 14192 ("Unleashing Prosperity Through Deregulation"), DOJ's notice eliminates several DEA proposals long cited as "in process".

Read More